Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata greatly harms quality of life, causing emotional and social issues.

New tools help assess eyebrow, eyelash, and nail changes in Alopecia Areata, improving understanding of patient experiences.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

Patients with alopecia areata have lower zinc levels, and zinc supplements might help.

Understanding patients' views on their illness can help improve their disease management.

Patient had scalp allergy from minoxidil; test helped identify cause and suggest alternative treatments.

Alopecia affects patients' quality of life, with younger patients and longer-lasting hair loss experiencing greater impact.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Some people with heavy hair shedding might actually have a hidden form of alopecia, which can be identified by specific hair changes.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Patients with alopecia areata might have a lower risk of stroke and possibly heart attack.

Patients with GATA2 deficiency show early skin symptoms that help diagnose the condition.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

Patients reduced searches for dermatology issues during COVID-19, indicating a need for better telehealth services.

Patients with renal disease may develop vitamin A toxicity even with low-dose supplements.

Methotrexate for rheumatoid arthritis often causes side effects like diarrhea, fatigue, and hair loss, especially at higher doses.

Patients with alopecia areata feel less regret about treatment decisions when they are involved in the decision-making process.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

Dr. Norwood's analysis highlights the need for careful patient selection and strategic hair transplant design to create a natural-looking hair density.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Patients with oral lichen planus or oral lichenoid reactions had worse cholesterol levels and a higher risk of obesity compared to healthy individuals.

Patients with schizophrenia have a high rate of skin diseases, with fungal infections and dermatitis being most common, and those on clozapine have a lower risk of fungal infections.

Patients with Type 1 diabetes should be screened for pernicious anemia.

Treating hair loss requires a comprehensive approach that addresses both physical and emotional aspects, with a focus on diagnosis, patient education, and good communication.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

Rosacea severely affects the quality of life for many patients in China, especially young adults and those with appearance-related jobs.

Patients with hair loss are much more likely to have body dysmorphic disorder than general dermatology patients.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.